The anteroventral periventricular nucleus (AVPV) is a nodal point in neural circuits regulating secretion of gonadotropin and contains sexually dimorphic populations of hormonally regulated dopamine-, dynorphin-, and enkephalin-containing neurons. Because the tyrosine hydroxylase (TH), prodynorphin (PDYN), and proenkephalin (PENK) genes contain CAMP response elements that control their expression in their promoters, we used histochemical methods to determine whether ovarian steroids alter expression of the CAMP response element-binding protein (CREB) in the AVPV. Because the ability of CREB to activate transcription depends on phosphorylation at Ser'33, we also evaluated the effects of acute steroid treatment on levels of phosphorylated CREB (pCREB) in AVPV neurons by using an antibody that differentiates between CREB and pCREB. Treatment of ovariectomized rats with estradiol treatments caused a significant induction in the number of pCREB-immunoreactive nuclei within 30 min that was maintained for at least 4 hr, but did not alter CREB immunostaining in the AVPV. Pretreatment with the estrogen antagonist Nafoxidine blocked this induction. In contrast, acute administration of progesterone to estrogen-primed animals suppressed and then increased pCREB staining in the AVPV at 30 and 60 min, respectively; no significant differences between experimental and control animals were apparent by 2 hr after progesterone treatment.
Double-labeling experiments showed that pCREB was colocalized with PDYN, PENK, or TH mRNA in the AVPV, suggesting that pCREB may mediate the effect of steroid hormones on gene expression in these neurons.
Key words: anteroventral periventricular nucleus; preoptic region; CAMP response element-binding protein: immunohistochemistry; ovarian steroids; estrogen; progesterone A unique function of the hypothalamus is its role in integrating both somatic and visceral sensory information with hormonal status to influence secretion of hormones such as luteinizing hormone and prolactin from the anterior pituitary (for review, see Swanson, 1987; Simerly, 1995a) . The anteroventral periventricular nucleus of the preoptic regions (AVPV) is a critical component of neural circuits that regulates gonadotropin secretion and represents an important site for hormone feedback on gonadotropinreleasing hormone (GnRH) neuronal function (for review, see Simerly, 1995b) . The AVPV contains one of the highest densities of neurons that express estrogen or progesterone receptors in the mammalian forebrain (for review, see Simerly, 1993; Simerly, 1995b) and receives strong inputs from other sexually dimorphic forebrain regions that are hormone-sensitive, such as the principal nucleus of the bed nuclei of the stria terminalis and the medial preoptic nucleus (Simerly and Swanson, 1988; Simerly et al., 1989; Canteras et al., 1992a,b; Canteras et al., 1995) . Thus, the function of neurons in the AVPV can be regulated by estrogen or progesterone via a direct action mediated by their cognate receptors, or regulated transsynaptically through projections from other hormone-sensitive regions. Recei ved Nov. 6, 1995; revised Feb. 6, 1996; accepted Feb. 9, 1996 Although primarily thought of as nuclear transcription factors that alter patterns of gene expression, steroid hormone receptors, or steroid hormone-binding proteins very similar to these receptors, also exert rapid effects on neuronal activity that cannot be explained purely by genomic mechanisms (Kelly, 1982; Harrison et al., 1989; Schumacher, 1990; Wong and Moss, 1992) . One way steroid hormones could effect such changes in neuronal signaling is by altering signal transduction pathways associated with second messengers, such as calcium and CAMP. Estrogen and progesterone influence gene expression in mammary carcinoma cells by altering the activity of adenylate cyclase and protein kinase C (Denner et al., 1990; Beck et al., 1992; Cho and Katzenellenbogen, 1993; Aronica et al., 1994) and the same signaling pathways may be hormonally regulated in neurons (Petitti and Etgen, 1990; Kow et al., 1994) .
The CAMP response element-binding protein (CREB) is a constitutively expressed transcription factor that is present in most hypothalamic neurons and has been shown to activate well characterized neuropeptide genes (Goodman, 1990; Armstrong and Montminy, 1993) . It acts primarily by binding to calcium-CAMP enhancer elements in the promoter region of CAMP-responsive genes, and either increases or deceases transcriptional activity depending on a variety of molecular factors, such as proximity to adjacent regulatory elements or complex protein-protein interactions with coactivators and other nuclear transacting factors (Chrivia et al., 1993; Meyer and Habener, 1993; Delmas et al., 1994; Kwok et al., 1994) . Cellular signaling mechanisms that alter either CAMP or calcium levels can activate phosphorylation of CREB, which is required for CREB to become a transcriptional regulator (Gonzalez and Montminy, 1989). Thus, phosphorylation May 1, 1996, 16(9):3035-3044 Gu et al. . Regulation of CREB Phosphotylation of CREB at Ser'"" by calcium-calmodulin-dependent protein kinase, or by protein kinase A, appears to determine whether CREB influences expression of genes that contain calcium-CAMP response elements (Ginty et al., 1992; Armstrong and Montminy, 1993) .
In the present study, we used the AVPV as a model system to investigate the acute effects of estrogen and progesterone on CREB. Previously, we identified sexually dimorphic populations of dopamine-, enkephalin-, and dynorphin-containing neurons in the AVPV that develop under the influence of sex steroid hormones and appear to be regulated by ovarian steroids in adults Simerly, 1989 Simerly, , 1991 . Moreover, tyrosine hydroxylase (TH), proenkephalin (PENK), and prodynorphin (PDYN) genes contain CAMP-responsive sequences in their promoters that bind CREB (Borsook et al., 1994; Cole et al., 1995; Lazaroff et al., 1995) and CAMP has been shown to regulate their expression in vitro (Lewis et al., 1987; Douglass et al., 1994) . Therefore, estrogen or progesterone may influence TH, PENK, and PDYN expression in the AVPV by altering CAMP signaling, which may involve regulating CREB activity. The present histochemical study was undertaken to determine whether estrogen or progesterone alter expression of CREB in the AVPV. Because the ability of CREB to activate transcription is dependent on phosphorylation of Ser'33, we also evaluated the effects of acute estrogen treatment on levels of phosphorylated CREB (pCREB) in AVPV neurons in vivo by using an antibody that differentiates between CREB and pCREB (Ginty et al., 1993) . Moreover, we used a combined immunohistochemical in situ hybridization method to determine if hormonally inducible pCREB is expressed in TH, PENK, or PDYN mRNA, which would support the possible involvement of CREB phosphorylation in the hormonal regulation of gene expression in the AVPV. This experiment was designed to confirm the effect of progesterone on the phosphorylation of CREB in the AVPV, and the dose and time course of RU486 injection have been proven to be physiologically effective .
MATERIALS AND METHODS

Animals
Tissue preparation and immunocytochemistry. In each experiment, animals were perfused on the same day. Each rat was deeply anesthetized with tribromoethanol and perfused within 2 min of anesthesia. A l-2 ml blood sample was rapidly collected from the right atrium of the heart immediately before perfusion. The fixation method follows that described by Hoffman et al. (1992) . After a brief rinse with normal saline (50-100 ml), each animal was perfused transcardially with ice-cold 4% paraformaldehyde (Electron Microscopy Sciences, Fort Washington, PA) in 0.1 M sodium phosphate buffer containing 2% acrolein (EM grade, Polysciences, Warrington, PA) at pH 6.8 for no >15 min, followed by 100 ml of saline rinse for -5 min. The brains were quickly removed and placed overnight in 25% aqueous sucrose. Twenty-micrometer-thick frozen sections through the AVPV of each brain (at a frequency of 1 in 4) were collected in chilled 0.02 M potassium PBS (KPBS). The sections were then incubated in 1% (w/v) sodium borohydride in KPBS for 15 min and rinsed thoroughly in KPBS. Free-floating sections were incubated in anti-rat CREB and anti-rat pCREB primary antisera (raised in rabbit; Upstate Biotechnology, Lake Placid, NY; lot Nos. 12174 and 11975, respectively) at 4°C with constant agitation for 72 hr. The characterization and specificity of the pCREB and CREB antibodies used in this study have been described previously (Ginty et al., 1993 in KPBS that contained 2% normal goat serum and 0.3% Briton X-100: After brief rinses in KPBS with 0.3% Triton X-100, the sections were then incubated at room temperature in a biotinylated goat anti-rabbit IgG secondary antiserum (Vector Laboratories, Burlingame, CA). The sections were rinsed in KPBS and incubated in the avidin-biotin complex (ABC) solution (Vector) at room temperature, and the incubations in the secondary antiserum and ABC solution were repeated, followed by several rinses in KPBS. The sections were then color-reacted with 0.03% diaminobenzidine (Sigma), 2.5% nickel ammonium sulfate, 0.2% D-glucose, and 0.04% ammonium chloride in 0.1 M acetate buffer. All sections in each experiment were stained at the same time in the same solutions to avoid systemic technical errors.
In situ hybridization. Animals were perfused transcardially with ice-cold 4% paraformaldehyde in 0.1 M borate buffer at pH 9.5, after which the brains were quickly removed and post-fixed overnight at 4°C in the same fixative containing 20% sucrose. Twenty-micrometer-thick frozen sections (at a frequency of 1 in 4) through the AVPV of each brain were collected in chilled 0.02 M KPBS that contained 0.25% paraformalde-hyde, pH 7.4, and mounted onto gelatin-subbed, poly-L-lysine-coated microscope slides from the same buffer, but lacking the paraformaldehyde. After a 30 min proteinase K digestion (10 &ml at 37°C) and acetylation (0.0025% at room temperature), the sections were dehydrated in ascending alcohols and dried under vacuum overnight.
The hybridization procedures used here are based on those reported by Cox et al. (1984) and are described in detail elsewhere (Simmons et al., 1989; Simerly et al., 1990 The stained sections were mounted onto gelatinand poly-L-lysine-coated microscope slides. After a 15 min proteinase K digestion (5 pg/ml at 37°C) and acetylation 0.0025% at room temperature, the sections were dehydrated in ascending alcohols and dried under vacuum for at least 2 hr. Procedures of in situ hybridization followed those described above. T7 polymerase was used to transcribe ""P-labeled antisense cRNA probe from a 280 bp cDNA insert derived from a PstI/KpnI restriction fragment, which corresponds to nucleotides 1242-1522 of the rat TH gene (Lewis et al., 1987) (Yoshikawa et al., 1984) . After hybridization and posthybridization processing, the sections were exposed to DuPont Cronex x-ray films for 4 d before being dipped in NBT-2 liquid emulsion.
The et al., 1975; Hess et al., 1981; Urbanski, 1990) . All the samples in each experiment were run in a single assay, with an intra-assay variation of <8%, and the lower limits of detection were 5 pg/tube in the estrogen assay, ~3.2% intra-assay variation, and 12 pg/tube lower limits of detection in progesterone assay.
RESULTS
Regulation of CREB and pCREB by estrogen in the AUPU
Treatment of ovariectomized female rats with EB caused an increase in serum levels of estradiol (E2) that was slightly above physiological levels within 5 min after injection, but E2 levels increased rapidly to supraphysiological levels by 30 min, and levels remained in the supraphysiological range for at least 40 0 I I I I Smin 15min 30min lh 4h Figure I . Experiment I: E2 profile. Serum E2 levels (X 100 pg/ml) of ovariectomized female rats that received subcutaneous injections of EB and were killed at 5, 15, and 30 min, and 1 or 4 hr after injection. 4 hr (Fig. 1) . However, this hormone treatment did not produce a significant change in either the number of CREBimmunoreactive nuclei or the density of CREB mRNAcontaining neurons in the AVPV compared with labeling obtained in animals treated with vehicle alone (Fig. U,B) , suggesting that estrogen has no acute effect on expression of CREB in the AVPV. In contrast, the same treatment caused a marked increase in the density of pCREB-immunoreactive nuclei in the AVPV (Fig. 2C,D) . Although there was no significant difference in the numbers of stained cells at either 5 or 15 min after treatment, by 30 min, when serum E2 levels peaked, the AVPV contained -50% more pCREB-immunoreactive nuclei in hormone-treated animals compared with the number of stained nuclei in the AVPV of parallel oil-treated controls (Fig. 3 , Table 1 ). This apparent induction in nuclear levels of pCREB was maintained for at least 4 hr. To test the specificity of the estrogenic induction of pCREB immunoreactivity in the AVPV, we evaluated the influence of E2 treatment on pCREB staining in animals that were pretreated with the anti-estrogen Nafoxidine. Intraperitoneal injections of Nafoxidine have been reported to block the action of E2 on sexual behavior and to reduce estradiol binding in the hypothalamus by -80% within 6 hr (Wade and Blaustein, 1978) . This effect is apparently maintained for up to 4 d. In the present study, pre- (shaded bars) and killed at 5, 1.5, and 30 min, and 1 or 4 hr after injection. Asterisks indicate significantly greater mean numbers compared with the ovariectomized female rats treated with oil. Right, Ratio of mean numbers of pCREB-immunoreactive neurons in the AVPV of ovariectomized female rats treated with EB (oVx+EB) and those in control animals treated with oil {Oxx+fN) at 5, 15, and 30 min, and 1 or 4 hr after injection.
treatment of ovariectomized female rats with Nafoxidine (4 mg/ animal) blocked the ability of EB to increase levels of pCREB immunoreactivity in nuclei of AVPV neurons 4 hr after treatment.
Regulation of CREB and pCREB by progesterone in the AVPV The influence of P4 treatment on pCREB staining was evaluated in ovariectomized rats implanted with silastic capsules containing E2. These capsules produced levels of E2 in plasma in the normal physiological range. After receiving subcutaneous injections of P4, serum P4 levels increased within 30 min, were maintained at 50-70 pg/ml for at least 4 hr, and then declined to low levels by 24 hr after treatment (Fig. 4) . In contrast to the effects of EB treatment on pCREBimmunoreactive nuclei in the AVPV, P4 treatment decreased numbers of pCREB-stained nuclei in the AVPV within 30 min. This significant decrease was followed by a greater than twofold increase in the number of pCREB-immunoreactive nuclei 30 min later (Fig. 5 , Table 2 ). Levels of pCREB staining in the AVPV declined after 1 hr, and no significant differences were apparent between experimental and control animals by 2 hr after progesterone treatment. This biphasic effect of P4 on pCREB staining appeared to be specific, because pretreatment with progesterone receptor antagonist RU486 blocked the suppression and induction of pCREB staining in the AVPV at 30 and 60 min. The distribution of CREB-immunoreactive nuclei in animals treated with progesterone was similar to that described for EBtreated rats in experiment 1 (see above). No significant differences Table 2 . Influence of P,-treatment on phosphorylation of CBEB in AVPV in E,-primed rats in the numbers of stained neurons in the AVPV were observed between the P4-treated and control groups. This observation was verified by the results of in situ hybridization experiments, which showed no apparent change in levels of CREB mRNA in the AVPV of P4-treated animals relative to those of control animals.
Colocalization of pCREB with TH, PDYN, and PENK mRNAs To determine whether hormone treatments induce expression of pCREB specifically in TH, PDYN, or PENK mRNA-containing neurons, we performed a series of combined immunohistochemiCal/in situ hybridization experiments. Two separate groups of experimental animals with either 1 hr EB treatment or 1 hr E2 + P4 treatment were used in these experiments. Although processing sections for immunocytochemistry before in situ hybridization reduced the density of silver grains over labeled cells relative to sections processed for in situ hybridization alone, immunostaining did not alter the overall distribution of PDYN, PENK, and TH mRNAcontaining neurons in the AVPV identified in doubly stained material. Approximately 26 and 28% of the PDYN mRNA-containing cells had clearly stained pCREB-immunoreactive nuclei in EB-and E2 + P4-treated animals, respectively (Fig. 6A , Table 3 ). However, the percentage of PENK mRNA-containing neurons in the AVPV that were doubly labeled for pCREB appeared to be somewhat higher; 39% of PENK-labeled cells were doubly labeled in EBtreated animals, and 56% were doubly labeled in E2 + P4-treated rats (Fig. 6B, Table 3 ). Approximately 33% of TH mRNA-containing neurons in the AVPV had clearly stained pCREB-immunoreactive nuclei in either EB-or E2 + PCtreated rats (Table 3) . 
DISCUSSION
The results of this study indicate that the activity of the transcription factor CREB is regulated in AVPV neurons by both E2 and P4. Acute treatment of ovariectomized rats with subcutaneous injections of E2 produced high levels of plasma E2 within 30 min after injection and was accompanied by a significant increase in nuclear staining for pCREB. The exact temporal relationship between the observed increases in pCREB and E2 stimulation of AVPV neurons remains unresolved because there is an unknown delay between the time of injection and when the local concentration of E2 in the AVPV increases. However, plasma levels of E2 increased rapidly in our animals between 15 and 30 min after treatment. Thus, it appears that AVPV neurons are exposed to increased levels of E2 between 15 and 30 min after treatment, the period immediately preceding the observed increase in pCREB staining. Although it may appear to be surprising that levels of pCREB staining did not return to baseline 4 hr after treatment, this may be because plasma levels of E2 remained high throughout the time points studied. Treatment of E2-primed rats with P4 resulted in elevated plasma levels of P4 that reached proestrus levels by 30 min after injection and returned to baseline within 24 hr. The increase in plasma P4 levels correlated with an equally rapid, but bimodal response in pCREB staining in the AVPV. Within 30 min of P4 treatment, pCREB first decreased then doubled after an additional 30 min before returning to baseline 1.5 min later. These hormonally regulated changes in nuclear levels of pCREB staining were not accompanied by similar changes in CREB immunostaining or mRNA levels, indicating that the reg- ulation of pCREB immunoreactivity observed in the AVPV is attributable to hormonal regulation of CREB phosphorylation as opposed to regulation of CREB gene expression, or changes in nuclear levels of CREB protein. Moreover, the rapid effects of the hormone treatments on pCREB staining are also not consistent with the synthesis of new protein, however, this possibility has not been examined experimentally. Although the antisera we used can differentiate between phospholylated and nonphosphorylated forms of CREB, pCREB antibody also appears to recognize ATF-like proteins (Ginty et al., 1993) , so our results may reflect hormonal regulation of phosphorylation of these proteins as well. In general, our results are consistent with other studies that evaluated physiological regulation of CREB phosphorylation in response to photic stimuli, salt loading, or stress, which suggests that CREB phosphorylation may mediate neuronal responses to a variety of physiological stimuli. A rapid increase in pCREB staining was observed in the suprachiasmatic nucleus in light/dark entrained hamsters exposed to light during their subjective night (Ginty et al., 1993) . Similarly, treatment of transgenic mice with hypertonic saline induced pCREB staining in neurons that express a proenkephalin-p-galactosidase fusion gene within 10 min of injection (Borsook et al., 1994) . Although we did not observe a significant change in pCREB staining in the AVPV until 30 min after injection, the increase in pCREB-immunoreactive nuclei correlates with the first marked increase in plasma levels of E2. The bimodal response of CREB phosphorylation to P4 also appears to be quite rapid, because plasma levels of P4 were not elevated significantly until 30 min after injection. Estrogen (Insel, 1, 1996, 16(9):3035-3044 Gu et al. l Regulation of CREB Phosphorylation 1990) and progesterone (Watson et al., 1993) have been reported to induce levels of Fos immunoreactivity in AVPV neurons, but these responses appear to be delayed somewhat relative to CREB phosphorylation, which is consistent with the suggestion that activation of CREB may contribute to increased c&s gene expression (Sheng et al., 1990) . The hormonal regulation of pCREB immunoreactivity in the AVPV appears to be receptor-mediated, because pretreatment with the anti-estrogen Nafoxidine blocked the effects of E2 on pCREB immunostaining, and pretreatment of EZprimed rats with the antiprogestin RU486 blocked the biphasic effect of P4 on pCREB. Nafoxidine has been shown previously to reduce E2 receptor binding and prevent receptor-mediated actions of E2 on reproductive behavior (Wade and Blaustein, 1978) . Similarly, RU486 is a potent P4 antagonist that binds irreversibly to the PR and can block physiological effects of circulating P4 on gonadotropin secretion . However, the molecular mechanism for the action of the ER and PR on CREB phosphorylation is unknown, and ovarian steroids have been reported to alter neuronal activity in regions that do not express their cognate receptors (Smith et al., 1987 .
Although transcriptional regulation by steroid hormone receptors has traditionally been viewed as a separate regulatory pathway from that involving stimulus transcription coupling mediated by second messengers, recent evidence suggests that there is a substantial amount of crosstalk between these two classes of signal transduction pathways. For example, Power and colleagues demonstrated that dopamine antagonists can alter the ability of the PR to activate gene expression, perhaps by influencing phosphorylation of the receptor (Power et al., 1991) and dopaminestimulated increases in hypothalamic CAMP levels are enhanced during proestrus in normally cycling rats (Barr et al., 1983) . changes in CREB phosphorylation with changes in transcription. The hormonal induction of pCREB in PENK mRNAcontaining neurons was surprising given that neither E2 nor P4 treatment causes significant changes in PENK gene expression (Simerly, 1991 (Simerly, ,1992 . However, a small but significant decrease in PENK mRNA was detected in intact female rats during proestrus (R. Simerly et al., unpublished data) , which may reflect the combined effects of both endocrine and neural factors yet to be identified.
Whether E2 and P4 regulate CREB phosphorylation in AVPV neurons by acting directly through their cognate hormone receptors expressed in the same cells, or act via the activation of hormone-sensitive neurons that provide inputs to AVPV neurons is not resolved. Most of the neurons in the AVPV express receptors for ovarian steroid hormones (Simerly et al., in press) , and systemic injections of E2 alter the electrophysiological activity of neurons in the region of the AVPV (Kubo et al., 1975) . However, the AVPV receives strong inputs from other forebrain regions containing neurons that express high levels of estrogen and progesterone receptors, such as the medial preoptic nucleus and arcuate nucleus of the hypothalamus (Simerly and Swanson, 1988; Simerly et al., 1990; Simerly, 1993 Simerly, , 1995a . Thus, E2 and P4 may regulate phosphorylation of CREB in AVPV neurons transsynaptically by stimulating the activity of neurons in such regions (Armstrong and Montminy, 1993) . A preliminary report of increased staining for pCREB in the medial preoptic nucleus in response to E2 treatment is consistent with this possibility (Zhou and Dorsa, 1994) .
Although these results suggest that CREB phosphorylation in the AVPV may mediate the effects of steroid hormones on TH, PDYN, and possibly PENK gene expression, the physiological importance of these molecular events is unknown. The results of Changes in CAMP levels, or activation of PKA and PKC, may influence the action of steroid hormone receptors in mammary carcinoma cells (Denner et al., 1990; Beck et al., 1992; Cho and Katzenellenbogen, 1993 ) and steroid hormones have been shown to regulate CAMP-mediated gene expression through modulation of the CAMP system (Aronica et al., 1994) . Less information is available regarding acute effects of steroid hormones on neuronal signal transduction, but estrogen and/or progesterone have been shown to alter production of CAMP and IP, (Kow and Mobbs, 1994) as well as to influence neuronal signaling in response to neurotransmitters (Kow and Pfaff, 198.5; Petitti and Etgen, 1989, 1990; Lagrange et al., 1994 ).
P4 appears to have biphasic effects on the secretion of recent anterograde transport studies indicate that neurons in the AVPV project directly to a subpopulation of GnRH-containing neurons in the rostra1 part of the preoptic region (Gu and Simerly, 1994) although the identity of neurotransmitters expressed in this projection has not been demonstrated. This latter observation is particularly interesting because the distribution of GnRH cells that receive AVPV inputs overlaps with that of GnRH neurons that show hormonally induced changes in Fos immunoreactivity (Lee et al., 1990a,b) , suggesting that changes in c-fos expression in GnRH neurons may be attributable to transsynaptic activation by hormonally stimulated AVPV neurons. The impact of CREB activation in AVPV dynorphin-containing neurons on gonadotropin secretion is equally unclear. Abundant pharmacological luteinizing hormone in estrogen-primed rats with short-term evidence supports an inhibitory role for opioid peptides on luteintreatments causing increased secretion of luteinizing hormone, izing hormone secretion and suggests that this inhibition is regubut P4 exerts negative feedback effects 24 hr later (Barraclough lated by circulating ovarian steroid hormones (Kalra, 1993 (Kalra, ). et al., 1986 . It is interesting to speculate that the biphasic Dynorphin-containing neurons in the AVPV are sexually dimoreffects of P4 on CREB phosphorylation observed in the AVPV phic, and PDYN mRNA is reduced on the afternoon of proestrus may participate in mediating the biphasic effects of P4 on (Simerly, 1991 (Simerly, , 1992 , suggesting that the impact of dynorphinGnRH secretion, although at present there is no convincing containing projections from the AVPV on postsynaptic targets evidence to support this suggestion. Whether the changes in will be reduced on the afternoon of proestrus during the preovulevels of pCREB in AVPV neurons specifically influence exlatory surge. We therefore propose that the induction of CREB pression of TH and PDYN is unknown, but the inhibition of phosphorylation in dopaminergic and dynorphin-containing neu-TH and the stimulation of PDYN expression by E2 may be rons of the AVPV may represent an important molecular commediated by hormonal regulation of CREB phosphorylation. ponent of hormonal feedback on neural systems that regulate Our double-labeling experiments indicate that E2 and P4 reggonadotropin secretion. ulate the phosphorylation of CREB in at least a subpopulation of these neurons, but clarification of this issue will require a REFERENCES detailed analysis of TH and PDYN gene expression in the Abercrombie M (1946) Estimation of nuclear population from mic-AVPV by using intronic probes to more directly correlate rotomic sections. Anat Ret 94:239-247.
